Prothia answers: A simple cost/benefit analysis reveals the following:
–Using a 90$ reimbursement per test, 5tests per month nearly cover the $480 monthly fee
–500 uses/tests (in 5 years) times $90 reimbursement per test yields benefit of $45,000
–Cost is $13.800
–Device will pay for itself in less than 2 years
Internal rate of return is 34% compounded annually
Note: (Physical Therapy) test billing CPT codes are 97750 (Physical Performance Test) and 95831 (Range of Motion Measure and Report). The information on these codes is based upon what we understand has worked successfully in some places sometimes in the past; one of our Customer verified a $125 reimbursement with payers. It is up to your institution to check with your payers if and how much they will pay for procédures.
Please note that it is incumbent upon your organization to create a financiel pro forma that works for you. (Some organizations are using a model where the device cost is built into the surgical fee, for example; others are planning to use the device to complete the total package care and improve decision-making especially in non-surgical insufficient knees.) can the Prothia-GNRB impact the overall market value of our organization?Prothia Answers: An organization with state-of-the-art equipment and staff trained to use it effectively has much greater value than a comparable organization with a “low-tech” armamentarium
Manager Asks: How can the Prothia-GNRB impact the overall market value of our organization?Prothia Answers: An organization with state-of-the-art equipment and staff trained to use it effectively has much greater value than a comparable organization with a “low-tech” armamentarium.
An analogy is the market value of a home with a garage compared to a home without one.
Manager Asks: Can the Prothia-GNRB help prove the efficacy of our ACL surgery and rehabilitation?Prothia Answers: Prothia-GNRB provides objective clinical data showing the condition of the ACL graft, after surgery and throughout the rehabilitation process. Using results-based medicine with objective, reliable data provides proof to the patient and the payer, that you are delivering results and value. You can also stop the therapy when you obtain the objective set.
Manager Asks: Can the Prothia-GNRB help us obtain better clinical results?Prothia Answers: Prothia-GNRB provides objective data about the condition of the ACL graft immediately post-operatively as well as during the rehabilitation process. For instance, it can show whether there is divergence from normal values in ACL laxity and related instability (e.g., abnormal slope/stiffness values).
If abnormal values and instability are detected immediately post-op or during rehab., these data provide the clinician with an opportunity to take remedial action.
For example, if the graft shows to be unstable immediately post-op, the orthopedic surgeon can use stabilizing measures such as a brace, to help stabilize and heal the graft, so that the patient will not be apt to cause it damage through overly-aggressive use of the knee.
If after 30 days post-op, for example, the graft shows out-of-norm values for laxity and slope, the orthopaedic surgeon and PT can work together to decelerate rehabilitation to bring values back into normal ranges, during the first 2 to 3 months post-op, which are the most critical for monitoring and managing the graft. Prothia and Prothia-GNRB studies show that after 3 months, it is likely impossible to manage the graft back to normal limits, using rehab. and pro-active techniques.
The Prothia-GNRB can also be used to provide guiding data when surgery and rehab. results go well, to help get the patient out earlier and complete the process faster.
In summary, the Prothia-GNRB provides objective, measurable and reliable data for guiding ACL rehabilitation to ensure and maximize successful outcomes.
Manager Asks: Can the Prothia-GNRB help our organization get more referrals and patients?Prothia Answers: The presence of the device may render the center marginally more attractive for referring clinicians and their patients.
The estimated impact can only be made by yourselves; however, a 5% increase in ACL-type patients may serve as a guideline or basis.
Manager Asks: Can the Prothia-GNRB help us attract and keep better, high-quality staff?Prothia Answers: Although it is difficult to assign a dollar value to the effect of a richer technical platform, it can be helpful in an environment where qualified and motivated staff are difficult to find.
Manager Asks: Can the Prothia-GNRB provide any value in helping us justify or prove the need for ACL surgery or rehabilitation?
Prothia Answers: The Prothia-GNRB can confirm and/or complement orthopaedic physical tests (e.g., Lachman) and MRI diagnosis, related to ACL full and partial tears. For example, in the case of a full tear, the device provides objective, measurable and precise data confirming a tear. Specifically, a side-to-side ACL laxity differential of 3 mm and slope differential of greater than 10 confirms an ACL tear.
The precise measurements which the device provides can also be used to help complement MRI diagnosis in the case of ACL partial tears, which can be more difficult to detect. Used in combination with MRI, the Prothia-GNRB can help improve the overall accuracy of ACL partial tear detection.
By providing precise and reliable data about the condition of the ACL graft post-op, the device can guide the timing and intensity of rehabilitation to optimize and ensure success. The Prothia-GNRB gives the orthopaedic surgeon and rehabilitation staff (e.g., PT) precise data to show whether the graft is healing properly during the critical period of 2 to 3 months post-op.